• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Risk factors for severe complications of the novel influenza A(H1N1): analysis of patients hospitalized in Italy

tetano

Editor, Senior Moderator
Clin Microbiol Infect. 2010 Jun 1. [Epub ahead of print]
Risk factors for severe complications of the novel influenza A(H1N1): analysis of patients hospitalized in Italy.

Bassetti M, Parisini A, Calzi A, Maria Bobbio Pallavicini F, Cassola G, Artioli S, Anselmo M, Pagano G, Rezza G, Viscoli C; for the Ligurian H1N1 Collaborative Group.

Infectious Diseases Division, San Martino Hospital and University of Genoa School of Medicine, Genoa, Italy.
Abstract

Eighty-one patients affected by the novel influenza A(H1N1), hospitalized in North-western Italy, were studied. The median age was 32 years (range, 1- 81). Fifty-six (69%) had an underlying medical condition, including lung disorders (asthma or COPD) in 34%, and obesity in 25%. Half of them had pneumonia, 12% were admitted to ICU, and 3% died. Antiviral treatment was initiated in 75% of patients started within 48 hours. Older age and lung and neurocognitive disorders were associated with severe disease and death.

PMID: 20518797 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20518797
 
Back
Top Bottom